Plasma derivative · BLA
Eloctate NDC 71104-805
antihemophilic factor (recombinant), fc fusion protein · Kit · Intravenous · Bioverativ Therapeutics Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71104-805-01 | 71104080501 | 1 KIT in 1 KIT (71104-805-01) * 3 mL in 1 VIAL (71104-487-08) * 3 mL in 1 SYRINGE (71104-035-01)Marketed from Sep 6, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Eloctate
- Generic name (nonproprietary)
- antihemophilic factor (recombinant), fc fusion protein
- Dosage form
- Kit
- Route
- Intravenous
- Labeler
- Bioverativ Therapeutics Inc.NDC labeler code 71104
- Product type
- Plasma derivative
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 125487
- Marketing start
- Listing expires
- Identifiers
- Product ID 71104-805_e600c559-32d8-4818-b600-141cc0d74ceaSPL ID e600c559-32d8-4818-b600-141cc0d74cea
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N471104080501followed by a unit qualifier and the quantityPackage 71104-0805-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 71104-805
- What is NDC 71104-805?
- 71104-805 is the product NDC for Eloctate kit, listed with the FDA by Bioverativ Therapeutics Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Eloctate (Antihemophilic Factor (Recombinant), Fc Fusion Protein).
- Who is the labeler?
- Bioverativ Therapeutics Inc., NDC labeler code 71104. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Eloctate?
- 9 other product NDCs are listed under this name. See all Eloctate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Eloctate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-808 | 71104-0808-01 |
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-806 | 71104-0806-01 |
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-807 | 71104-0807-01 |
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-804 | 71104-0804-01 |
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-801 | 71104-0801-01 |
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-802 | 71104-0802-01 |
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-803 | 71104-0803-01 |
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-809 | 71104-0809-01 |
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-810 | 71104-0810-01 |
Other NDCs under BLA 125487
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-808 |
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-806 |
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-807 |
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-804 |
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-801 |
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-802 |
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-803 |
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-809 |
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-810 |